TY - JOUR
TI - The COVID-19 Pandemic and the Need for an Integrated and Equitable
Approach: An International Expert Consensus Paper
AU - Gerotziafas, Grigoris T.
AU - Catalano, Mariella
AU - Theodorou, Yiannis
AU - and Van Dreden, Patrick
AU - Marechal, Vincent
AU - Spyropoulos, Alex C.
AU - and Carter, Charles
AU - Jabeen, Nusrat
AU - Harenberg, Job
AU - Elalamy,
AU - Ismail
AU - Falanga, Anna
AU - Fareed, Jawed
AU - Agathaggelou, Petros and
AU - Antic, Darko
AU - Antignani, Pier Luigi
AU - Bosch, Manuel Monreal and
AU - Brenner, Benjamin
AU - Chekhonin, Vladimir
AU - Colgan, Mary-Paula and
AU - Dimopoulos, Meletios-Athanasios
AU - Douketis, Jim
AU - Elnazar, Essam Abo
AU - and Farkas, Katalin
AU - Fazeli, Bahare
AU - Fowkes, Gerry
AU - Gu,
AU - Yongquan
AU - Gligorov, Joseph
AU - Ligocki, Mark A.
AU - Indran, Tishya
AU - and Kannan, Meganathan
AU - Kantarcioglu, Bulent
AU - Kasse, Abdoul Aziz
AU - and Konstantinidis, Kostantinos
AU - Leivano, Fabio
AU - Lewis, Joseph and
AU - Makatsariya, Alexander
AU - Mbaye, P. Massamba
AU - Mahe, Isabelle and
AU - Panovska-Stavridis, Irina
AU - Olinic, Dan-Mircea
AU - Papageorgiou,
AU - Chryssa
AU - Pecsvarady, Zsolt
AU - Pillon, Sergio
AU - Ramacciotti,
AU - Eduardo
AU - Abdel-Razeq, Hikmat
AU - Sabbah, Michele
AU - Sassi, Mouna and
AU - Schernthaner, Gerit
AU - Siddiqui, Fakiha
AU - Shiomura, Jin and
AU - Slama-Schwok, Anny
AU - Wautrecht, Jean Claude
AU - Tafur, Alfonso and
AU - Taher, Ali
AU - Klein-Wegel, Peter
AU - Zhai, Zenguo
AU - Zoubida, Tazi
AU - Mezalek
JO - Thrombosis and Haemostasis
PY - 2021
VL - 121
TODO - 08
SP - 992-1007
PB - Georg Thieme Verlag KG
SN - 0340-6245
TODO - 10.1055/a-1535-8807
TODO - COVID-19; SARS-CoV-2; pandemic; thrombosis; health care systems
TODO - Background One year after the declaration of the coronavirus disease
2019 (COVID-19) pandemic by the World Health Organization (WHO) and
despite the implementation of mandatory physical barriers and social
distancing, humanity remains challenged by a long-lasting and
devastating public health crisis.
Management Non-pharmacological interventions (NPIs) are efficient
mitigation strategies. The success of these NPIs is dependent on the
approval and commitment of the population. The launch of a mass
vaccination program in many countries in late December 2020 with mRNA
vaccines, adenovirus-based vaccines, and inactivated virus vaccines has
generated hope for the end of the pandemic.
Current Issues The continuous appearance of new pathogenic viral strains
and the ability of vaccines to prevent infection and transmission raise
important concerns as we try to achieve community immunity against
severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and
its variants. The need of a second and even third generation of vaccines
has already been acknowledged by the WHO and governments.
Perspectives There is a critical and urgent need for a balanced and
integrated strategy for the management of the COVID-19 outbreaks
organized on three axes: (1) P revention of the SARS-CoV-2 infection,
(2) Detection and early diagnosis of patients at risk of disease
worsening, and (3) Anticipation of medical care (PDA).
Conclusion The “PDA strategy” integrated into state policy for the
support and expansion of health systems and introduction of digital
organizations (i.e., telemedicine, e-Health, artificial intelligence,
and machine-learning technology) is of major importance for the
preservation of citizens’ health and life world-wide.
ER -